Biophoton Therapy in Lyme Disease: Neurophysiological and Bioenergetic Improvements Over 4 Weeks - A Case Report

Authors

  • James Z Liu First Institute of All Medicines, 139 Pittsburg Road, Butler, PA 16001, USA Author
  • Mariola A Smotrys First Institute of All Medicines, 139 Pittsburg Road, Butler, PA 16001, USA Author
  • Seth D Robinson Tesla BioHealing, Inc. 111 McCoy Street, Milford, DE 19963, USA Author
  • Hui X Yu Tesla BioHealing, Inc. 111 McCoy Street, Milford, DE 19963, USA Author
  • Sherry X Liu Tesla BioHealing, Inc. 111 McCoy Street, Milford, DE 19963, USA Author
  • Devin R Liu Tesla BioHealing, Inc. 111 McCoy Street, Milford, DE 19963, USA Author
  • Helen Y Gu First Institute of All Medicines, 139 Pittsburg Road, Butler, PA 16001, USA Author

DOI:

https://doi.org/10.47363/k7kcqx74

Keywords:

Lyme Disease, Biophoton Therapy, Quantitative EEG, Event-Related Potentials, Systemic Bioenergetics, Mitochondrial Dysfunction

Abstract

Background: Lyme disease frequently results in persistent neurological dysfunction even after standard antibiotic therapy, with symptoms including cognitive impairment, fatigue, and impaired vigilance. Biophoton therapy, a non-invasive intervention that emits ultra-weak photons, has been proposed to restore mitochondrial function, support systemic bioenergetics, and improve neural efficiency.

Methods: We present a case study of a 54-year-old female patient with chronic Lyme disease who underwent continuous biophoton therapy for four weeks using two Tesla BioHealers. Neurophysiological outcomes were assessed at baseline, Week 2, and Week 4 using quantitative EEG (qEEG), event-related potentials (ERPs), and behavioral reaction times. Patient-reported outcomes (SF-36) and pulmonary function (spirometry) were also measured. Systemic energy balance was evaluated using Bio-Well gas discharge visualization technology to quantify organ-specific and integral energy changes.

Results: The patient demonstrated progressive improvement in quality of life (SF-36: ~1,200 baseline to ~3,300 at Week 2) and pulmonary function (spirometry: ~150 baseline to ~430 at Week 2). EEG findings showed early normalization of posterior alpha activity, reduced theta/beta ratio, and sustained improvement in reaction time (470 ms baseline to 411 ms a Week 4). ERP analysis revealed a transient improvement in visual processing latency at Week 2. Bio-Well assessments indicated a systemic shift from fragmented and depleted energy at baseline to coherent, balanced energy fields by Week 4. All organs with baseline energy below 4 Joules (×10-²) increased above this threshold, with a mean overall energy gain of +0.73 per organ.

Conclusion: Biophoton therapy was associated with multidimensional improvements in cortical efficiency, systemic energy balance, and functional outcomes in a patient with chronic Lyme disease. These findings highlight the potential of biophoton therapy as a novel non-invasive intervention for post-infectious neurological dysfunctions, warranting further validation in controlled clinical studies.

Author Biographies

  • James Z Liu, First Institute of All Medicines, 139 Pittsburg Road, Butler, PA 16001, USA

    First Institute of All Medicines, 139 Pittsburg Road, Butler, PA 16001, USA

  • Mariola A Smotrys, First Institute of All Medicines, 139 Pittsburg Road, Butler, PA 16001, USA

    First Institute of All Medicines, 139 Pittsburg Road, Butler, PA 16001, USA

  • Seth D Robinson, Tesla BioHealing, Inc. 111 McCoy Street, Milford, DE 19963, USA

    Tesla BioHealing, Inc. 111 McCoy Street, Milford, DE 19963, USA

  • Hui X Yu, Tesla BioHealing, Inc. 111 McCoy Street, Milford, DE 19963, USA

    Tesla BioHealing, Inc. 111 McCoy Street, Milford, DE 19963, USA

  • Sherry X Liu, Tesla BioHealing, Inc. 111 McCoy Street, Milford, DE 19963, USA

    Tesla BioHealing, Inc. 111 McCoy Street, Milford, DE 19963, USA

  • Devin R Liu, Tesla BioHealing, Inc. 111 McCoy Street, Milford, DE 19963, USA

    Tesla BioHealing, Inc. 111 McCoy Street, Milford, DE 19963, USA

  • Helen Y Gu, First Institute of All Medicines, 139 Pittsburg Road, Butler, PA 16001, USA

    First Institute of All Medicines, 139 Pittsburg Road, Butler, PA 16001, USA

Downloads

Published

2025-09-04

Issue

Vol. 7 No. 9 (2025): Volume 7 Issue 9

Section

Articles